Références

1. Olsen CM, Pandeya N, Green AC, Ragaini BS, Venn AJ, Whiteman DC. Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk. Public Health Res Pract 2022 ; 32 : e3212203.

2. Verkouteren JAC, Ramdas KHR, WakkeeM, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017 ; 177 : 359-72.

3. Hammas K, Nardin C, Boyer S, Michel C, Aubin F, Woronoff AS. Incidence and trends of first basal cell carcinomas in France between1980 and 2019: a regional population-based registry study. Br J Dermatol 2024 ; 191 : 519-28.

4. Gupta N, Ruiz ES. Current Perspectivesin the Treatment of Locally Advanced Basal Cell Carcinoma. Drug Des Devel Ther 2022 ; 16 : 183-90.

5. Schierbeck J, Vestergaard T, Bygum A. Skin Cancer Associated Genodermatoses: A Literature Review. Acta Derm Venereol 2019 ; 99 : 360-9.

6. Peris K, Fargnoli MC, Kaufmann R, et al. European consensus-based inter-disciplinary guideline for diagnosis and treatment of basal cell carcinoma- update 2023. Eur J Cancer 2023 ; 192 : 113254.

7. Negrutiu M, Danescu S, Popa T, Focșan M, Vesa ȘC, Baican A. Advancements in Basal Cell Carcinoma Diagnosis: Non-Invasive Imaging and Multimodal Approach. J Clin Med 2023 ; 13 : 39.

8. Kanitakis J, Bahadoran P, Braun R, et al. La microscopie confocale par réflectance in vivo en dermatologie: proposition de terminologie en langue française [In vivo reflectance confocal microscopy in dermatology: a proposal concerning French terminology]. Ann Dermatol Venereol 2013 ; 140: 678-86.

9. Anaes. Recommandations pour la pratique clinique. Prise en charge du carcinome basocellulaire de l’adulte. Ann Dermatol Venereol 2004 ; 131 : 669-77.

10. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Basal Cell Skin Cancer, Version 1. 2024. National Comprehensive Cancer Network, 2024.

11. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004 ; 50 : 722-33.

12. Prince GT, Cameron MC, Fathi R, Alkousakis T. Topical 5-fluorouracil in dermatologic disease. Int J Dermatol 2018 ; 57 : 1259-64.

13. Koumprentziotis IA, Rompoti N, Liopyris K, Nicolaidou E, Stratigos A. Photodynamic Therapy for the Treatment of Basal Cell Carcinoma: A Comprehensive Review of Randomized Controlled Trials. Dermatol Pract Concept 2024 ; 14 : e2024105.

14. Drucker AM, Adam GP, Rofeberg V, et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med 2018 ; 169 : 456-66.

15. Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012 ; 366 : 2171-9.

16. Lear JT, Migden MR, Lewis KD, et al. Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-monthanalysis of the randomized phase2 BOLT study. J Eur Acad Dermatol Venereol 2018 ; 32 : 372-81.

17. Garrouteigt C, Broc G, Legrand A, Quintard B, Beylot-Barry M. Facilitators of and obstacles to consultation in patients with advanced basal cell carcinoma: a French pilot study. Arch Dermatol Res 2021 ; 313 : 829-35.

18. American Academyof Dermatology. How to apply sunscreen: https://www.aad.org/public/everyday-care/sun-protection/shade-clothing-sunscreen/ how-to-apply-sunscreen

19. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015 ; 373 : 1618-26.

20. Alkassis S, Shatta M, Wong DJ. Therapeutic Advances in Advanced Basal Cell Carcinoma. Cancers (Basel) 2024 ; 16 : 3075.

21. Fernández-Galván A, Rodríguez-Jiménez P, González-Sixto B, Abalde- Pintos MT, Butrón-Bris B. Topical and Intralesional Immunotherapy for the Managementof Basal Cell Carcinoma. Cancers (Basel) 2024 ; 16 : 2135.

22. Wang X, Peng J, Meng C, Feng F. Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies. Chem Sci 2024 ; 15 : 12234-257.

23. Alimardani V, Rahiminezhad Z, DehghanKhold M, et al. Nanotechnology-based cell-mediated delivery systems for cancer therapy and diagnosis. Drug Deliv Transl Res 2023 ; 13 : 189-221.